In the realm of pharmaceuticals, where hope, health and heavy-duty regulatory complexity converge, we’re witnessing one of the most profound yet quiet revolutions in modern medicine: redefining innovation and manufacturing to make next-generation medicines accessible and affordable. This transformation is more than a shift in process; it’s a redefinition of how modern medicine is conceived, produced, and delivered.